Skip to content

The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adults.

Ingestion of a Novel Algae Protein Source on Rested and Post Exercise Muscle Protein Synthesis Rates.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06852547
Acronym
CALM
Enrollment
15
Registered
2025-02-28
Start date
2025-02-23
Completion date
2026-03-01
Last updated
2025-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional Intervention

Keywords

novel protein, protein synthesis, older adults, alge

Brief summary

To assess the rested and postexercise muscle protein synthetic response following the ingestion of a flavourless algae protein source compared with whey protein in older adults.

Interventions

DIETARY_SUPPLEMENTprotein

protein

Sponsors

University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Males and Females BMI 18.5 - 30 kg/m2 Aged 65-80 years Recreationally Active

Exclusion criteria

Body mass index (BMI) \<18.5 or \>30 kg/m2 Any metabolic impairments Any cardiovascular impairments High blood pressure (≥140/90 mmHg) Any gastrointestinal disorders Any medications known to affect protein and/or amino acid metabolism A personal or family history of epilepsy, seizures or schizophrenia, motor disorder Chronic over the counter use of pharmaceuticals (\> 1 month) Allergic to any of the whole foods included in the study

Design outcomes

Primary

MeasureTime frameDescription
Postprandial muscle protein synthesis4 hoursunilateral exercise followed by protein ingestion (algae / whey)

Countries

United Kingdom

Contacts

Primary ContactFreyja A.D Haigh, PhD
fh357@exeter.ac.uk+447917608163

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026